Literature DB >> 22833520

Protection against oxidative DNA damage and stress in human prostate by glutathione S-transferase P1.

Rajnee Kanwal1, Mitali Pandey, Natarajan Bhaskaran, Gregory T Maclennan, Pingfu Fu, Lee E Ponsky, Sanjay Gupta.   

Abstract

The pi-class glutathione S-transferase (GSTP1) actively protect cells from carcinogens and electrophilic compounds. Loss of GSTP1 expression via promoter hypermethylation is the most common epigenetic alteration observed in human prostate cancer. Silencing of GSTP1 can increase generation of reactive oxygen species (ROS) and DNA damage in cells. In this study we investigated whether loss of GSTP1 contributes to increased DNA damage that may predispose men to a higher risk of prostate cancer. We found significantly elevated (103%; P < 0.0001) levels of 8-oxo-2'-deoxogunosine (8-OHdG), an oxidative DNA damage marker, in adenocarcinomas, compared to benign counterparts, which positively correlated (r = 0.2) with loss of GSTP1 activity (34%; P < 0.0001). Silencing of GSTP1 using siRNA approach in normal human prostate epithelial RWPE1 cells caused increased intracellular production of ROS and higher susceptibility of cells to H2 O2 -mediated oxidative stress. Additionally, human prostate carcinoma LNCaP cells, which contain a silenced GSTP1 gene, were genetically modified to constitutively express high levels of GSTP1. Induction of GSTP1 activity lowered endogenous ROS levels in LNCaP-pLPCX-GSTP1 cells, and when exposed to H2 O2 , these cells exhibited significantly reduced production of ROS and 8-OHdG levels, compared to vector control LNCaP-pLPCX cells. Furthermore, exposure of LNCaP cells to green tea polyphenols caused reexpression of GSTP1, which protected the cells from H2 O2 -mediated DNA damage through decreased ROS production compared to nonexposed cells. These results suggest that loss of GSTP1 expression in human prostate cells, a process that increases their susceptibility to oxidative stress-induced DNA damage, may be an important target for primary prevention of prostate cancer.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  DNA damage; glutathione S-transferase P1; oxidative stress; prostate cancer; reactive oxygen species

Mesh:

Substances:

Year:  2012        PMID: 22833520      PMCID: PMC4018746          DOI: 10.1002/mc.21939

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  43 in total

Review 1.  Mechanisms of induction of cytosolic and microsomal glutathione transferase (GST) genes by xenobiotics and pro-inflammatory agents.

Authors:  Larry G Higgins; John D Hayes
Journal:  Drug Metab Rev       Date:  2011-05       Impact factor: 4.518

Review 2.  The many faces of glutathione transferase pi.

Authors:  O Vasieva
Journal:  Curr Mol Med       Date:  2011-03       Impact factor: 2.222

3.  Green tea polyphenols causes cell cycle arrest and apoptosis in prostate cancer cells by suppressing class I histone deacetylases.

Authors:  Vijay S Thakur; Karishma Gupta; Sanjay Gupta
Journal:  Carcinogenesis       Date:  2011-11-23       Impact factor: 4.944

Review 4.  Reactive oxygen species (ROS)--induced genetic and epigenetic alterations in human carcinogenesis.

Authors:  Dominique Ziech; Rodrigo Franco; Aglaia Pappa; Mihalis I Panayiotidis
Journal:  Mutat Res       Date:  2011-03-16       Impact factor: 2.433

5.  Vegetable and fruit intake after diagnosis and risk of prostate cancer progression.

Authors:  Erin L Richman; Peter R Carroll; June M Chan
Journal:  Int J Cancer       Date:  2011-08-30       Impact factor: 7.396

6.  Sulforaphane and alpha-lipoic acid upregulate the expression of the pi class of glutathione S-transferase through c-jun and Nrf2 activation.

Authors:  Chong-Kuei Lii; Kai-Li Liu; Yi-Ping Cheng; Ai-Hsuan Lin; Haw-Wen Chen; Chia-Wen Tsai
Journal:  J Nutr       Date:  2010-03-17       Impact factor: 4.798

7.  Hydrogen peroxide mediates EGCG-induced antioxidant protection in human keratinocytes.

Authors:  Leonilla Elbling; Irene Herbacek; Rosa-Maria Weiss; Christian Jantschitsch; Michael Micksche; Christopher Gerner; Heinrich Pangratz; Michael Grusch; Siegfried Knasmüller; Walter Berger
Journal:  Free Radic Biol Med       Date:  2010-08-12       Impact factor: 7.376

Review 8.  The role of inflammation and infection in prostate cancer: Importance in prevention, diagnosis and treatment.

Authors:  H K Koul; B Kumar; S Koul; A A Deb; J S Hwa; P Maroni; A van Bokhoven; M S Lucia; F J Kim; R B Meacham
Journal:  Drugs Today (Barc)       Date:  2010-12       Impact factor: 2.245

Review 9.  Glutathione transferases and development of new principles to overcome drug resistance.

Authors:  Andrea Sau; Francesca Pellizzari Tregno; Francesco Valentino; Giorgio Federici; Anna Maria Caccuri
Journal:  Arch Biochem Biophys       Date:  2010-05-28       Impact factor: 4.013

10.  Markedly enhanced colon tumorigenesis in Apc(Min) mice lacking glutathione S-transferase Pi.

Authors:  Kenneth J Ritchie; Shaun Walsh; Owen J Sansom; Colin J Henderson; C Roland Wolf
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-13       Impact factor: 11.205

View more
  21 in total

1.  Oxidative stress marker 8-hydroxyguanosine is more highly expressed in prostate cancer than in benign prostatic hyperplasia.

Authors:  Shinji Ohtake; Takashi Kawahara; Yukari Ishiguro; Teppei Takeshima; Shinnosuke Kuroda; Koji Izumi; Hiroshi Miyamoto; Hiroji Uemura
Journal:  Mol Clin Oncol       Date:  2018-07-03

2.  Induction of reactive oxygen species generation inhibits epithelial-mesenchymal transition and promotes growth arrest in prostate cancer cells.

Authors:  Trinath P Das; Suman Suman; Chendil Damodaran
Journal:  Mol Carcinog       Date:  2013-03-08       Impact factor: 4.784

Review 3.  Modulation of signaling pathways in prostate cancer by green tea polyphenols.

Authors:  Naghma Khan; Hasan Mukhtar
Journal:  Biochem Pharmacol       Date:  2012-10-03       Impact factor: 5.858

Review 4.  Minireview: the molecular and genomic basis for prostate cancer health disparities.

Authors:  Isaac J Powell; Aliccia Bollig-Fischer
Journal:  Mol Endocrinol       Date:  2013-04-22

Review 5.  Telomeres and telomerase in prostate cancer development and therapy.

Authors:  Mindy Kim Graham; Alan Meeker
Journal:  Nat Rev Urol       Date:  2017-07-04       Impact factor: 14.432

6.  NEAT1 paraspeckle promotes human hepatocellular carcinoma progression by strengthening IL-6/STAT3 signaling.

Authors:  Shuai Wang; Qian Zhang; Qinlan Wang; Qicong Shen; Xiang Chen; Zhenyang Li; Ye Zhou; Jin Hou; Bowen Xu; Nan Li; Xuetao Cao
Journal:  Oncoimmunology       Date:  2018-08-06       Impact factor: 8.110

7.  MicroRNA Regulating Glutathione S-Transferase P1 in Prostate Cancer.

Authors:  Savita Singh; Girish C Shukla; Sanjay Gupta
Journal:  Curr Pharmacol Rep       Date:  2015-04-01

8.  HES5 silencing is an early and recurrent change in prostate tumourigenesis.

Authors:  Charles E Massie; Inmaculada Spiteri; Helen Ross-Adams; Hayley Luxton; Jonathan Kay; Hayley C Whitaker; Mark J Dunning; Alastair D Lamb; Antonio Ramos-Montoya; Daniel S Brewer; Colin S Cooper; Rosalind Eeles; Anne Y Warren; Simon Tavaré; David E Neal; Andy G Lynch
Journal:  Endocr Relat Cancer       Date:  2015-01-05       Impact factor: 5.678

9.  An investigation into the association between DNA damage and dietary fatty acid in men with prostate cancer.

Authors:  Karen S Bishop; Sharon Erdrich; Nishi Karunasinghe; Dug Yeo Han; Shuotun Zhu; Amalini Jesuthasan; Lynnette R Ferguson
Journal:  Nutrients       Date:  2015-01-08       Impact factor: 5.717

10.  A pilot study to investigate if New Zealand men with prostate cancer benefit from a Mediterranean-style diet.

Authors:  Sharon Erdrich; Karen S Bishop; Nishi Karunasinghe; Dug Yeo Han; Lynnette R Ferguson
Journal:  PeerJ       Date:  2015-07-02       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.